drugset / Trial / NCT03395574

Effect of Terlipressin on Cerebral Oxygen Saturation During Liver Transplantation

NCT03395574

Phase 2 Completed 30 enrolled Kasr El Aini Hospital
RandomizedParallel-groupQuadruple-blindTreatment

Summary

in our study the investigators aim to assess the effect of terlipressin on cerebral oxygenation monitored by cerebral oxymetry and cerebral blood flow measured by transcranial doppler.

Timeline

Start
2018-01-25
Primary completion
2018-11-25
Completion
2018-11-25

Drugs

EvaluationDrugModalityDoseRoute
Subject Terlipressin Peptide 160 ug

Indications

No indication recorded.